Chromadex Corp Stock OTC Bulletin Board
Equities
CDXC
US1710771007
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 23 | Chromadex Announces Inaugural Major Grocery Debut of Tru Niagen® At Sprouts Farmers Market | CI |
Apr. 09 | Roth MKM Raises Price Target on ChromaDex to $6 From $4.25, Keeps Buy Rating | MT |
Financials (USD)
Sales 2024 * | 97.09M | Sales 2025 * | 114M | Capitalization | 260M |
---|---|---|---|---|---|
Net income 2024 * | -1M | Net income 2025 * | 4M | EV / Sales 2024 * | 2.68 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.27 x |
P/E ratio 2024 * |
860
x | P/E ratio 2025 * |
59.8
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 58.93% |
Latest transcript on Chromadex Corp
Managers | Title | Age | Since |
---|---|---|---|
Robert Fried
CEO | Chief Executive Officer | 64 | 15-07-08 |
Frank Jaksch
FOU | Founder | 55 | 98-12-31 |
Brianna Gerber
DFI | Director of Finance/CFO | 44 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Rubin
BRD | Director/Board Member | 63 | 17-03-26 |
Hamed Shahbazi
BRD | Director/Board Member | 49 | 22-08-08 |
Frank Jaksch
FOU | Founder | 55 | 98-12-31 |
1st Jan change | Capi. | |
---|---|---|
+1.77% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-8.83% | 26.59B | |
+7.44% | 25.49B | |
-23.01% | 18.12B | |
+30.56% | 12.24B | |
-1.82% | 11.76B | |
+8.35% | 11B |
- Stock Market
- Equities
- CDXC Stock
- CDXC Stock